Renewable Design for Clobetasol Gentamicin - cefquinime sulfate injection – Xinanran
Renewable Design for Clobetasol Gentamicin - cefquinime sulfate injection – Xinanran Detail:
[Usage and dosage] Intramuscular injection: for one use, every 1 kg body weight, the pig 0.08 to 0.12ml, once a day for 3 to 5 days.
[cautions](1) Animals allergic to β-lactam antibiotics are forbidden.
(2) Allergy to penicillin and cephalosporin antibiotics are not exposed to this product.
(3) Shake well before use.
[Withdrawal period] Pig 72 hours.
[Specifications] 100Ml:2.5g per C 23H 24N 6O 5S 2
[Package] 100Ml
[Storage] keep in a cool place.
[Period of validity] Two years
[Manufacturing enterprise ] Hebei Xinanran Biotechnology Co., Ltd.
[Factory address] No. 6 First Row East, Konggang Street Economic Development Zone, Xinle City, Hebei Province.
Tel: 0311-85695628/85695638 Postal code: 050700
Product detail pictures:
Related Product Guide:
Good quality comes 1st; assistance is foremost; business enterprise is cooperation" is our business enterprise philosophy which is regularly observed and pursued by our company for Renewable Design for Clobetasol Gentamicin - cefquinime sulfate injection – Xinanran , The product will supply to all over the world, such as: US, Leicester, India, Our company has built stable business relationships with many well-known domestic companies as well as oversea customers. With the goal of providing high quality products to customers at low cots, we've been committed to improving its capacities in research, development, manufacturing and management. We have honored to receive recognition from our customers. Till now we have now passed ISO9001 in 2005 and ISO/TS16949 in 2008. Enterprises of "quality of survival, the credibility of development" for the purpose, sincerely welcome domestic and foreign businessmen to visit to discuss cooperation.
By Jean from Somalia - 2017.12.02 14:11
Cooperate with you every time is very successful, very happy. Hope that we can have more cooperation!
By EliecerJimenez from Poland - 2018.12.22 12:52
Write your message here and send it to us